Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export Proteins
Heike Gutmann(National Institutes of Health), David S. Miller(Southwestern Medical Center), Gert Fricker(Heidelberg University), Michael Toeroek(National Institutes of Health), Jürgen Drewe(Max Zeller Söhne (Switzerland))
Cited by 179
Related Papers
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
|Journal of Clinical Investigation|2002|360
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
|Journal of Clinical Investigation|2002|345
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
|Pharmaceutical Research|2010|325